ROB'E is a dynamic MedTech startup that is revolutionizing the field of diagnostic echocardiography and interventional cardiology with its groundbreaking, AI-powered robotic probe controller for echocardiographic systems. This cutting-edge technology has the potential to significantly expand the market for structural heart disease therapies and democratize access to advanced treatments for a broad range of patients. By bringing this innovative solution to market, ROB'E is poised to transform the way structural heart diseases are diagnosed and treated, improving patient outcomes and quality of life for countless individuals around the world.